Concerto Biosciences reinvents humanity’s relationship with microbes. We envision a future where each of us fine-tunes the microbial communities in us, on us, and around us to stay healthy. To pave the way, Concerto invented a platform to measure, in ultra-high throughput, how microbes behave in the presence of each other. These measurements enable Concerto to see the world as it is: a massive underlying network of microbial interactions that shapes the health of our bodies and our planet. The network reveals new products—“ensembles” of microbes that work in concert to perform tasks that benefit people. Our first ensembles rehabilitate the skin microbiome, providing protection from previously intractable diseases like eczema and restoring health to millions.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $47.54M
Founded date: 2020
Investors 7
| Date | Name | Website |
| 08.11.2022 | M Ventures | m-ventures... |
| - | Taihill Ve... | taihill.vc |
| 15.11.2023 | MassVentur... | mass-ventu... |
| 22.12.2022 | Skylight I... | skylightin... |
| - | Impact Sci... | impactscie... |
| - | Endless Fr... | endlessfro... |
| - | Axial VC | axialvc.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.11.2022 | Series A | $23M | - |
| 22.03.2022 | - | $24.54M | - |
Mentions in press and media 6
| Date | Title | Description |
| 21.05.2025 | Concerto Biosciences (Life Sciences, '20-21) Maps Skin Microbial Interactions Through Millions of Tested Combinations | - |
| 26.06.2024 | Concerto Biosciences Receives FDA Investigational New Drug Clearance for Live Biotherapeutic Product to Treat Atopic Dermatitis | The company's first product is a synergistic combination of topical bacteria that may treat atopic dermatitis. CAMBRIDGE, Mass., June 26, 2024 /PRNewswire/ -- Concerto Biosciences, a Cambridge-based biotechnology company, announced today th... |
| 06.02.2023 | Concerto Biosciences Announces Strategic Business Development Hire | Didier Vingadassalom, Ph.D., to Drive New Partnerships as Concerto’s Senior Director, Business Development and Company’s First Employee Dedicated to Business Development Concerto Biosciences, a biotechnology company designing microbial comm... |
| 04.11.2022 | StartUPDATES: New Developments for Healthcare Startups | Carrum Health extended the reach of its bundled cancer care through an alliance with City of Hope, one of the largest cancer research and treatment organizations in the United States. First launched on the East Coast last year, Carrum Healt... |
| 02.11.2022 | Concerto Biosciences Raises $23M in Series A Funding | Concerto Biosciences, a Cambridge, MA-based biotechnology company, raised $23M in Series A funding. The round was led by Safar Partners with participation from Horizons Ventures and M Ventures. Representatives from Safar Partners and M Vent... |
| 02.11.2022 | Concerto Biosciences Raises $23M in Series A | CAMBRIDGE, MA, Concerto Biosciences, a biotechnology company, announced that it raised $23 million in a Series A funding round. >> Click here for more funding data on Concerto Biosciences >> To export Concerto Biosciences fu... |